If you don't find the timing of the sell of these shares to be in poor taste, once again, I wouldn't be investing in the biotechnology sector. I'm merely saying what's on a lot of our minds.
If the ceo hadn't shown us the true nature of his character in the first year of his tenure this wouldn't be as big of an issue but, well, he did reveal himself to all of us.